Schonfeld Strategic Advisors’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.57M | Buy |
58,924
+10,764
| +22% | +$470K | 0.02% | 769 |
|
|
2025
Q1 | $1.32M | Sell |
48,160
-167,320
| -78% | -$4.58M | 0.01% | 1057 |
|
|
2024
Q4 | $8.67M | Buy |
215,480
+36,294
| +20% | +$1.46M | 0.05% | 311 |
|
|
2024
Q3 | $8.48M | Sell |
179,186
-110,277
| -38% | -$5.22M | 0.06% | 281 |
|
|
2024
Q2 | $8.64M | Sell |
289,463
-90,979
| -24% | -$2.72M | 0.06% | 342 |
|
|
2024
Q1 | $15.3M | Sell |
380,442
-57,191
| -13% | -$2.3M | 0.1% | 215 |
|
|
2023
Q4 | $11.1M | Buy |
+437,633
| New | +$11.1M | 0.07% | 287 |
|
|
2023
Q1 | – | Sell |
-17,400
| Closed | -$434K | – | 2275 |
|
|
2022
Q4 | $434K | Buy |
+17,400
| New | +$434K | ﹤0.01% | 1586 |
|
|
2020
Q4 | – | Sell |
-6,672
| Closed | -$216K | – | 1677 |
|
|
2020
Q3 | $216K | Buy |
+6,672
| New | +$216K | ﹤0.01% | 1161 |
|